The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of metastatic chromophobe renal cell carcinoma (chrRCC) in the targeted therapy era: Results from the International Metastatic Renal Cell Cancer Database Consortium.
 
Steven Yip
No Relationships to Disclose
 
Jose Manuel Ruiz Morales
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis/Pfizer
 
Anna Paola Fraccon
No Relationships to Disclose
 
Umberto Basso
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jae-Lyun Lee
Honoraria - Astellas Pharma; Astellas Pharma; Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Bayer; Exelixis; Janssen; Novartis; Pfizer
 
Georg A. Bjarnason
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca
 
Benoit Beuselinck
Consulting or Advisory Role - Novartis
Speakers' Bureau - GlaxoSmithKline; Novartis; Pfizer
Research Funding - novartis; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Ravindran Kanesvaran
Honoraria - Bayer; Novartis; Pfizer
Consulting or Advisory Role - bayer; Novartis; Pfizer
 
James Brugarolas
Consulting or Advisory Role - Bethyl Laboratories
Research Funding - Peloton Therapeutics
Patents, Royalties, Other Intellectual Property - Peloton Therapeutics
 
Konstantinos Koutsoukos
No Relationships to Disclose
 
Simon Yuen Fai Fu
No Relationships to Disclose
 
Takeshi Yuasa
Expert Testimony - Astellas Pharma; Pfizer
 
Carmel Jo Pezaro
Honoraria - Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Novartis
Travel, Accommodations, Expenses - Novartis; Sanofi
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Seagen
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer